29.12.2014 Views

ABSTRACTS - World Psychiatric Association

ABSTRACTS - World Psychiatric Association

ABSTRACTS - World Psychiatric Association

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

specifically, these studies have either investigated single fiber tracts<br />

(i.e., using region of interest analysis) or they have relied upon error<br />

prone DTI normalization to the template space (i.e., voxel based morphometry,<br />

VBM analyses). Here the focus is on whole brain analytic<br />

approaches, where existing VBM DTI data analyses are presented as<br />

well as recent methodological advances in studying WM alterations<br />

in schizophrenia. Two new methods of whole brain data analysis,<br />

atlas based segmentation and group based spectral clustering, are<br />

introduced, and results using these new methods are reported from a<br />

dataset that includes 25 chronic schizophrenia subjects and 25<br />

healthy controls. Findings are presented from the two methods and<br />

the implications from these studies are discussed, as well as the<br />

advantages and disadvantages of using these methods vs. more conventional<br />

VBM methods.<br />

RS2.3.<br />

DIFFUSION TENSOR TRACTOGRAPHY<br />

IN FIRST-EPISODE SCHIZOPHRENIA<br />

G. Price, M. Cercignani, G. Parker, D. Altmann, T. Barnes,<br />

G. Barker, E. Joyce, M. Ron<br />

Institute of Neurology, University College, London, UK;<br />

Imperial College Faculty of Medicine, London, UK;<br />

Institute of Psychiatry, King’s College, London, UK; Santa Lucia<br />

Foundation, Rome, Italy; Imaging Science and Biomedical<br />

Engineering, University of Manchester, UK; Medical Statistics<br />

Unit, London School of Hygiene and Tropical Medicine,<br />

London, UK<br />

Disconnectivity abnormalities in the cortex and connecting white<br />

matter pathways may explain the symptoms and cognitive abnormalities<br />

of schizophrenia. Recently, diffusion imaging tractography has<br />

made it possible to study white matter pathways in detail in vivo and<br />

in this paper a corpus callosum study (18 patients and 21 controls)<br />

and an uncinate fasciculus study (19 patients and 23 controls) are presented<br />

for a sample of patients with first-episode schizophrenia using<br />

a probabilistic tractography algorithm. In the study of the corpus callosum,<br />

seed points were placed in the splenium and genu to track fibre<br />

tracts crossing these regions. A multi-threshold approach and multiple<br />

linear regressions were used to explore group differences. Fractional<br />

anisotropy (FA) was reduced in tracts crossing the genu, and to<br />

a lesser degree the splenium, in patients compared with controls. In<br />

the study of the uncinate fasciculus, two seed points were used to isolate<br />

the tract in each hemisphere. FA and probability of connection<br />

were obtained for every voxel in the tract and the group means and<br />

distributions of these variables were compared. The FA distribution,<br />

as measured by the squared coefficient of variance, was reduced in the<br />

left uncinate fasciculus in the patient group, indicating that the number<br />

of voxels with high FA values was reduced, suggesting abnormalities<br />

in the core of the tract. These studies suggest that there are subtle<br />

abnormalities in structural connectivity in patients that may involve<br />

aberrant connectivity in the core of the white matter tract.<br />

RS2.4.<br />

WHITE MATTER VOLUME, ANISOTROPY,<br />

AND TRACT TARGETING QUALITY IN<br />

SCHIZOPHRENIA: FIXED OR PROGRESSIVE<br />

M.S. Buchsbaum, S. Mitelman, E.L. Canfield, J. Schneiderman,<br />

K.-W. Chu, J.J. Entis, E.A. Hazlett, M. Haznedar, I. Nenadic,<br />

J. Zhang, J. Friedman<br />

Mount Sinai School of Medicine Department of Psychiatry,<br />

New York, NY, USA<br />

Several studies have suggested progressive focal gray matter loss in<br />

schizophrenia, but longitudinal white matter changes in anisotropy<br />

have not yet been systematically assessed regionally. Two studies were<br />

conducted: a) diffusion-tensor and structural magnetic resonance<br />

imaging in a cohort of 49 schizophrenia patients and 16 controls<br />

scanned twice 4 years apart; patients were subdivided into good-outcome<br />

(n=23) and poor-outcome; b) 3T-MP-RAGE anatomical and<br />

diffusion tensor images on 111 patients with schizophrenia and 222<br />

normals. Placement of images in standard AC-PC position, coregistration<br />

of DT images to the anatomical images, computation of<br />

anisotropy and tract-angles was done with FSL. White matter and<br />

gray matter volumes and fractional anisotropy were parcellated into<br />

Brodmann areas and entered into multiway ANCOVA. In the followup<br />

sample at baseline, anisotropy was lower in patients and they<br />

showed larger white matter volume. Over four years, anisotropy<br />

declined more in controls bringing normal and schizophrenia levels<br />

closer; controls showed small white matter increases, again bringing<br />

them closer to patient values. For anisotropy and white matter,<br />

patients with good outcome showed a pattern not dissimilar to controls,<br />

but gray matter volume loss continued in poor-outcome<br />

patients. Tract angles changed little over time. In the cross-sectional<br />

sample, lower anisotropy was observed widely in schizophrenia, but<br />

most prominently in the frontal and temporal lobes. Both volumetric<br />

and anisotropy changes in white matter over time appear to be in the<br />

direction of effacement of between-groups differences among schizophrenia<br />

patients and controls. Tract angles and total length were<br />

reduced in schizophrenia, but less altered over time.<br />

RS3.<br />

CLINICAL FEATURES AND PHARMACOLOGICAL<br />

TREATMENT OF BIPOLAR MIXED DEPRESSIONS<br />

RS3.1.<br />

THE “TROUBLED WATER” OF TREATMENT<br />

OF BIPOLAR MIXED DEPRESSIONS<br />

F. Benazzi<br />

Hecker Psychiatry Research Center, Forlì, Italy; University<br />

of California at San Diego, CA, USA<br />

Bipolar depressions are difficult to treat. Mood stabilising agents are<br />

more effective for mania than depression. Only olanzapine/fluoxetine<br />

combination and quetiapine are FDA-approved for bipolar (type I)<br />

depression, but none of the antidepressants used in unipolar depression.<br />

While some controlled studies on bipolar depression have shown<br />

that antidepressants are not better than placebo or lithium, some large<br />

naturalistic studies (closer to “real-world” patients) have shown effectiveness<br />

of antidepressants. As bipolar depression is often mixed (i.e.,<br />

with concurrent manic/hypomanic symptoms), and most antidepressants<br />

studies have not been stratified according to mixed status, the<br />

results of these studies are questionable, as bipolar mixed depression<br />

may be worsened by antidepressants (statistically wiping out positive<br />

32 <strong>World</strong> Psychiatry 8:S1 - February 2009

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!